Glunova Biotech LLC

The European Union operates one of the most comprehensive chemical regulatory frameworks in the world. For research institutions importing synthetic peptides from outside the EU, three overlapping regulatory systems apply: REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals), CLP (Classification, Labelling and Packaging of substances and mixtures), and the EU customs framework. Navigating these correctly is the difference between seamless two-day clearance and a two-week customs hold with your temperature-sensitive material sitting in an un-refrigerated facility.

This guide covers the EU regulatory framework as it applies specifically to synthetic research peptide imports in 2026, with practical guidance on documentation, country-specific considerations, and customs clearance strategy.

The EU Regulatory Framework

Three regulations govern the import and handling of research chemicals — including synthetic peptides — in the EU:

• REACH (Regulation EC No 1907/2006) — the primary EU chemicals regulation. It governs registration, evaluation, authorisation, and restriction of chemical substances. For importers, REACH obligations attach to the “importer” (the EU-based entity receiving the substance), not the exporter. This means the receiving research institution in Germany, France, or the Netherlands bears the primary REACH compliance obligation for substances they import.
• CLP (Regulation EC No 1272/2008) — implements the UN Globally Harmonised System (GHS) for classification and labelling of chemical substances in the EU. CLP determines hazard classification, required labelling elements, and SDS (Safety Data Sheet) format for substances placed on the EU market, including those imported for research.
• BPR (Biocidal Products Regulation 528/2012) — generally not applicable to research peptide imports, but relevant if any peptide has antimicrobial claims or biocidal properties. For standard research peptides, BPR is typically not a concern.

REACH Considerations for Research Peptides

REACH registration is required for substances manufactured or imported into the EU above 1 tonne per year per legal entity. For most research peptide importers, quantities fall well below this threshold — a research institution importing grams or hundreds of grams of a specific peptide per year is far from the registration trigger.

More relevant for research peptide imports are the REACH exemptions:

Annex IV Exemptions

REACH Annex IV lists substances for which registration is not required due to their hazard profile being considered sufficiently well characterized. Most common research peptides — being non-toxic amino acid polymers — may qualify. However, the Annex IV list is specific; confirm whether your particular compound is listed before relying on this exemption.

Annex V Exemptions (Scientific Research and Development)

REACH Annex V, Entry 8 provides a full registration exemption for “substances used only in scientific research and development” when they are not placed on the market and are used in quantities below 1 tonne per year per site. This is the most practically relevant exemption for research peptide imports to academic and research institutions.

The key requirements for Annex V Entry 8 exemption:

• The substance is used only for scientific research and development purposes
• It is not placed on the EU market (i.e., not re-sold or distributed to third parties within the EU)
• Quantities remain below 1 tonne per year at the importing site
• The importer maintains records of research use and can demonstrate compliance if requested

PPORD (Product and Process Oriented Research and Development) Exemption

For larger quantities or for importers involved in development activities leading to commercial products, REACH Article 9 provides the PPORD exemption. This exempts substances from registration requirements for up to 5 years (renewable) when used in PPORD activities. The exemption covers up to 1 tonne per year by default; larger quantities require ECHA notification with justification. The PPORD notification must be submitted to ECHA by the EU importer before import.

Polymeric Peptide Considerations

REACH defines “polymers” (including polypeptides above a molecular weight threshold) as exempt from registration requirements under Article 2(9). Whether a specific synthetic peptide qualifies as a “polymer” under REACH depends on its molecular weight and structural characteristics. This is a technical determination that may require legal or regulatory affairs input for high-molecular-weight peptides.

CLP Classification and SDS Requirements

CLP classification determines what information must appear on labels and in Safety Data Sheets for research peptides imported into the EU. The practical requirements for research labs receiving peptide imports:

Safety Data Sheet Format

EU REACH Article 31 requires suppliers to provide an SDS in 16-section GHS format for any substance classified as hazardous under CLP, or supplied upon request for substances below hazard thresholds. For research peptides:

• The SDS must follow the 16-section EU format specified in REACH Annex II
• The SDS must be in the official language(s) of the destination EU member state — German for Germany, French for France, Dutch for the Netherlands, etc.
• The classification and hazard statements must reflect CLP-harmonised classification where available, or self-classification by the supplier where no harmonised classification exists

Classification of Research Peptides

Most synthetic research peptides — being amino acid polymers without known systemic toxicity at research quantities — are self-classified by manufacturers as substances that require minimal hazard labelling (often “not classified” under CLP for the primary hazard classes). The SDS will typically include precautionary statements relating to handling (P260 — do not breathe dust/aerosols; P280 — wear protective equipment) rather than acute toxicity or environmental hazard statements.

Multilingual SDS Requirements

This is the most frequently overlooked documentation requirement for non-EU exporters. A single English-language SDS is not sufficient for all EU destinations. Required languages include:

• Germany: German
• France: French
• Netherlands: Dutch (though English is broadly accepted by Dutch customs for professional/research use)
• Spain: Spanish
• Italy: Italian
• Poland: Polish

Glunova Biotech LLC provides EU-format SDS for primary destination countries. Contact us in advance of your order to confirm SDS availability in your required language.

Customs Documentation Package

For an EU research peptide import shipment to clear customs without holds, the following documents must be complete and consistent with each other:

• Commercial Invoice
  • Exporter and importer full legal name and address
  • Product description: “Synthetic research peptide — [compound name] — For laboratory research use only, not for human or veterinary use”
  • HS code: 2937.99 (hormones and hormone analogues, including polypeptides — not elsewhere classified)
  • Quantity (grams or milligrams) and unit price
  • Total value in USD or EUR
  • Incoterms (typically DAP — Delivered At Place — or DDP for duty-paid delivery)
  • Country of origin: United States of America
• Air Waybill (AWB) — issued by carrier; must match invoice description exactly
• Certificate of Analysis (COA) — lot-specific; confirms compound identity and purity
• Safety Data Sheet (SDS) — 16-section EU format in destination country language
• EORI Number of EU Importer — Economic Operators Registration and Identification number, issued by the national customs authority. Research institutions should obtain an EORI number before their first import. Without it, customs clearance cannot proceed.
• Research Use Declaration — letter on institutional letterhead from the PI or procurement officer confirming research-only use, institutional affiliation, and compliance with applicable regulations

Country-Specific Notes

Germany

Germany is one of the more straightforward EU destinations for research peptide imports. Customs clearance at FRA (Frankfurt Airport) and MUC (Munich Airport) is efficient for clearly documented research material. BfArM (Bundesinstitut fur Arzneimittel und Medizinprodukte) notification is not required for synthetic peptides imported for non-clinical research use — BfArM oversight applies to approved medicinal products, not research chemicals. German-language SDS is required. VAT is 19%, recoverable by registered research institutions.

France

ANSES (Agence nationale de securite sanitaire de l’alimentation, de l’environnement et du travail) has oversight over certain chemicals under French law. For standard synthetic research peptides without known endocrine-disrupting properties, ANSES notification is generally not required. French-language SDS is required. French customs (DGDDI) at CDG (Paris Charles de Gaulle) applies standard clearance procedures for research chemicals with correct documentation.

Netherlands

AMS (Amsterdam Schiphol) is one of the most efficient European customs hubs, particularly for research and life sciences material. The Netherlands Customs Authority is experienced with research chemical clearance. Dutch-language SDS is technically required, though English-language SDS is routinely accepted for clearly identified research institution imports at AMS. The Netherlands is also a common transshipment hub — material destined for other EU countries often transits through AMS for final delivery.

United Kingdom (Post-Brexit)

Following Brexit, the UK operates a separate regulatory framework from the EU. Key differences for research peptide importers:

• UK REACH — separate from EU REACH, managed by HSE (Health and Safety Executive). The same REACH exemptions (scientific research, PPORD) exist under UK REACH but apply to UK-based importers independently from their EU obligations.
• EORI number — UK EORI number (GB prefix) is required for UK customs clearance, distinct from EU EORI (which will not work for UK clearance post-Brexit).
• SDS — must comply with UK GHS format (which broadly mirrors EU GHS). English-language SDS is acceptable for the UK.
• Duty — under the UK Global Tariff, HS 2937.99 from the US is typically 0% under MFN treatment.

Italy and Spain

Both are standard EU customs processes with no additional peptide-specific oversight beyond standard REACH/CLP compliance. Italian and Spanish language SDS respectively are required. Clearance at MXP (Milan Malpensa) and MAD (Madrid Barajas) is generally efficient for documented research material.

Common Customs Holds and How to Resolve Them

These are the most frequent causes of EU customs holds for research peptide shipments, and their resolution:

• Missing or incorrect-language SDS — The most common cause of holds at EU entry points. Resolution: have a correctly formatted SDS in the destination language ready before the shipment, transmitted electronically to the customs broker as a backup document. Prepare translated SDS in advance for recurring destination countries.
• HS code mismatch or challenge — If a customs officer challenges HS 2937.99 classification, the resolution is a binding tariff information (BTI) ruling from the national customs authority, or a reclassification letter from the exporter with justification referencing the compound’s chemical structure. Established research peptide suppliers maintain BTI rulings for their primary export destinations.
• End-use clarification request — Customs may request additional evidence of legitimate research use. A letter on institutional letterhead from the PI, addressed to the customs authority, confirming the research application and institutional identity resolves this in most cases within 1-2 business days.
• Quantity flag (above 1 gram for certain compounds) — Some EU member states apply additional scrutiny to research chemical imports above certain quantity thresholds, particularly for compounds with potential for misuse. Resolution depends on the specific compound and country; an end-use certificate from the receiving institution is typically sufficient.
• EORI not recognized or missing — If the EU importer’s EORI number is missing from shipping documents, clearance cannot proceed. Ensure the EORI number appears on both the commercial invoice and is registered with the customs broker before shipment.

VAT and Import Duty

• Import duty: Under WTO MFN (Most Favored Nation) treatment, synthetic peptides classified under HS 2937.99 from the United States are typically subject to 0% customs duty in the EU. Verify with your customs broker for the specific compound, as duty rates can vary by subheading and are subject to trade policy changes.
• VAT: EU VAT rates apply to the customs value (invoice value + freight + insurance) at the rate of the destination country — typically 19-25% depending on member state. Research universities and public research institutions are typically VAT-registered and can recover import VAT through standard VAT reclaim processes.
• Customs broker fees: Professional customs brokerage for a single research peptide shipment typically costs EUR 40-100 per consignment. Brokers specializing in life sciences and chemical imports provide faster processing and lower hold risk than general freight brokers.

Cold-Chain During EU Customs Clearance

EU customs clearance for express shipments (DHL, FedEx, UPS) is typically completed electronically before the physical shipment arrives, with customs formalities completed within hours of landing at the destination airport. For well-documented research peptide shipments, physical inspection is rare.

If a shipment is held for physical inspection, the customs facility may or may not have refrigeration. Key protections:

• Design cold-chain packaging to maintain temperature for at least 48 hours longer than the expected transit time — this buffer covers inspection delays
• Include a temperature data logger so the thermal record is preserved regardless of the hold duration
• Notify the receiving institution to monitor clearance status proactively; they can contact the customs authority to expedite release if a hold appears on the carrier’s tracking system
• For time-critical or high-value shipments, use a customs broker with pre-clearance capability (electronic filing before the physical shipment departs) to minimize clearance time at the destination port

Working with Your Customs Broker

For recurring EU research peptide imports, establishing a relationship with a customs broker familiar with life sciences and chemical imports saves significant time and hold risk. Provide your broker with:

• Standard product descriptions and HS codes for all compounds you regularly import
• Your institution’s EORI number (and UK EORI if applicable)
• Your VAT registration number for VAT reclaim
• A library of SDS documents in all required languages for your standard compounds
• A standard research use declaration letter that can be referenced quickly if needed
• Your supplier’s standard documentation package so the broker knows what to expect

Glunova Biotech LLC EU Shipping Process

We provide EU-ready documentation as standard with every international shipment. This includes a REACH-aligned SDS in the required destination language, 16-section EU GHS format, commercially invoiced with correct HS 2937.99 classification, and a research-use declaration template. For importers with EORI numbers, our documentation package is designed to support smooth customs clearance at all major EU entry points.

For German, French, Dutch, UK, and other European destinations, we have established documentation packages and customs broker relationships that support efficient clearance. EU import support is included in the quoted price — there are no documentation surcharges for standard destinations.

Contact us to discuss your specific EU import requirements: dylan.tom2012@gmail.com. For shipping timelines and carrier options, see our Shipping Information page.